1221269-96-0

Basic information

• Product Name: N-(4-fluorophenyl)-1-(2-methyl-4-(methylsulfonyl)phenyl)phthalazin-6-amine
• Synonyms: N-(4-fluorophenyl)-1-(2-methyl-4-(methylsulfonyl)phenyl)phthalazin-6-amine
• CAS NO: 1221269-96-0
• Molecular Weight: 407.468
• Mol File: 1221269-96-0.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N-(4-fluorophenyl)-1-(2-methyl-4-(methylsulfonyl)phenyl)phthalazin-6-amine(CAS DataBase Reference)
• NIST Chemistry Reference: N-(4-fluorophenyl)-1-(2-methyl-4-(methylsulfonyl)phenyl)phthalazin-6-amine(1221269-96-0)
• EPA Substance Registry System: N-(4-fluorophenyl)-1-(2-methyl-4-(methylsulfonyl)phenyl)phthalazin-6-amine(1221269-96-0)

Safety Data

• Hazardous Substances Data: 1221269-96-0(Hazardous Substances Data)

Upstream product

• 1011459-26-9 4,4,5,5-tetramethyl-2-(2-methyl-4-(methylsulfonyl)phenyl)-1,3,2-dioxaborolane 
• 1221270-31-0 1-chloro-N-(4-fluorophenyl)phthalazin-6-amine 

Relevant articles and documents

PHTHALAZINE COMPOUNDS AS p38 MAP KINASE MODULATORS AND METHODS OF USE THEREOF

The present invention comprises a new class of compounds useful for the prophylaxis and treatment of protein kinase mediated diseases, including inflammation and related conditions. The compounds have a general Formula I wherein A4, L, R1, R2, R3, R5 and m are as defined herein. The invention also comprises pharmaceutical compositions including one or more compounds of Formula I, uses of such compounds and compositions for treatment of p38 map kinase mediated diseases including rheumatoid arthritis, psoriasis, chronic obstructive pulmonary disease, ankylosing spondylitis, pain and other inflammatory disorders, as well as intermediates and processes useful for the preparation of compounds of Formula I.